Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains 
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 
Instagram Outage Disrupts Thousands of U.S. Users 
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate 
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine 
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links 
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile 
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering 
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies 
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports 
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns 
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit 
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO 
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks 
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 
LAS VEGAS, Jan. 12, 2016 (GLOBE NEWSWIRE) -- Miracle Flights, previously known as "Miracle Flights for Kids" or "Angel Planes," is seeking to reconnect with patients and families that flew with the organization prior to 2011.
The organization hopes to connect for the purpose of obtaining updates on past flight recipients, including current medical status, major life events, education, career, hobbies, passions, etc. Updated stories may be utilized as testimonials and/or for an upcoming PBS special on Miracle Flights. Recording will take place at the Miracle Flights headquarters in March, and some recipients may be asked to participate in the project. Former patients not interested in appearing publically are still encouraged to submit an update for archival purposes.
Those interested in connecting are encouraged to contact:
Charles Courtney
Director of Special Projects
[email protected]
702-261-0494
CONTACT: Charles Courtney
Director of Special Projects
[email protected]
702-261-0494
